Elliptic Laboratories ASA (OSL:ELABS)
3.175
-0.095 (-2.91%)
Jun 4, 2026, 12:59 PM CET
Elliptic Laboratories ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 74.02 | 43.06 | 76.39 | 115.58 | 178.22 | 218.15 |
Cash & Short-Term Investments | 74.02 | 43.06 | 76.39 | 115.58 | 178.22 | 218.15 |
Cash Growth | -3.59% | -43.63% | -33.91% | -35.15% | -18.30% | 118.76% |
Accounts Receivable | 82.84 | 81 | 110.94 | 60.61 | 40.5 | 29.03 |
Other Receivables | 8.92 | 6.7 | 6.59 | 6.36 | 5.65 | 17.7 |
Receivables | 91.76 | 87.7 | 117.52 | 66.97 | 46.15 | 46.72 |
Prepaid Expenses | - | 1.42 | 1.54 | 3.09 | 1.25 | 0.08 |
Other Current Assets | -0 | - | - | - | - | - |
Total Current Assets | 165.78 | 132.18 | 195.45 | 185.64 | 225.62 | 264.95 |
Property, Plant & Equipment | 13.62 | 12.41 | 16.66 | 19.91 | 2.26 | 2.79 |
Other Intangible Assets | 70.31 | 71.45 | 66.25 | 55.63 | 47.57 | 36.56 |
Long-Term Deferred Tax Assets | - | - | 75.42 | 78.17 | 68.84 | 62.53 |
Other Long-Term Assets | 4.77 | 5.62 | 7.25 | 8.86 | 5.04 | 4.52 |
Total Assets | 254.49 | 221.66 | 361.03 | 348.2 | 349.32 | 371.36 |
Accounts Payable | 2.15 | 2 | 1.3 | 3.86 | 1.67 | 3.03 |
Accrued Expenses | - | 18.56 | 15.03 | 13.08 | 9.33 | 8.42 |
Current Portion of Long-Term Debt | - | - | 2 | 4 | 4 | 4 |
Current Portion of Leases | 5.86 | 4.8 | 6.63 | 3.99 | 2.18 | 2.61 |
Other Current Liabilities | 16.83 | -0 | - | 0 | - | - |
Total Current Liabilities | 24.84 | 25.36 | 24.96 | 24.93 | 17.18 | 18.06 |
Long-Term Debt | - | - | - | 2 | 6 | 10 |
Long-Term Leases | 8.52 | 8.31 | 10.73 | 15.87 | 0.52 | 0.53 |
Other Long-Term Liabilities | - | 0 | - | -0 | - | 0 |
Total Liabilities | 33.36 | 33.67 | 35.69 | 42.8 | 23.7 | 28.59 |
Common Stock | 1.26 | 1.05 | 1.05 | 1.05 | 1.04 | 1.04 |
Additional Paid-In Capital | 415.67 | 359.96 | 359.83 | 355 | 345.52 | 342.55 |
Comprehensive Income & Other | -195.81 | -173.01 | -35.54 | -50.65 | -20.93 | -0.81 |
Shareholders' Equity | 221.13 | 188 | 325.34 | 305.4 | 325.62 | 342.77 |
Total Liabilities & Equity | 254.49 | 221.66 | 361.03 | 348.2 | 349.32 | 371.36 |
Total Debt | 14.38 | 13.11 | 19.35 | 25.86 | 12.71 | 17.14 |
Net Cash (Debt) | 59.64 | 29.95 | 57.04 | 89.72 | 165.51 | 201.01 |
Net Cash Growth | -0.49% | -47.49% | -36.43% | -45.79% | -17.66% | 162.69% |
Net Cash Per Share | 0.56 | 0.28 | 0.51 | 0.86 | 1.59 | 2.04 |
Filing Date Shares Outstanding | 126.34 | 105.29 | 105.27 | 104.84 | 104.07 | 103.84 |
Total Common Shares Outstanding | 126.34 | 105.29 | 105.27 | 104.84 | 104.07 | 103.84 |
Working Capital | 140.95 | 106.82 | 170.49 | 160.72 | 208.44 | 246.89 |
Book Value Per Share | 1.75 | 1.79 | 3.09 | 2.91 | 3.13 | 3.30 |
Tangible Book Value | 150.82 | 116.54 | 259.09 | 249.78 | 278.05 | 306.21 |
Tangible Book Value Per Share | 1.19 | 1.11 | 2.46 | 2.38 | 2.67 | 2.95 |
Machinery | 0.55 | 0.55 | 0.51 | 0.51 | - | - |